How Much Longer Will This Company Be Around?

Another round of cuts. Turn out the lights, the party's over.

 

Please elaborate. Sales or internal staffing (manufactoring, admin, research) cuts?

 

Both. Trying to cut to bare bones as last gasp to be purchased. Lipstick on the proverbial pig.

 

Thanks for the information. It will be interesting to see what the next few months have in store for this company.

 

Is ABT really going to buy this POS?

 

Hope not
It would be another colossal waste of money

Still don't have an indication and therefore unable to pay the reps

Bad move to buy this turd

 

Let's be honest, Abbott isn't buying anything in the peripheral space. They could care less. That division is the red headed stepchild of Abbott.

 

Abbott is not buying this pos. Looks like some info has leaked. So, what the heck. You heard it.

 

Peripheral use approval is likely by summer. Abbott to purchase for 240 million is what I am hearing from the buyer's side.

 

I would be shocked if IDEV does more than $50MM a year in sales. A $240MM price tag would be completely asinine.

Again, once the docs are off the payroll, who is going to use it as a workhorse product? Not going to happen. ABT has put enough money into Absolute. They will have an SFA indication in less than 12 months. To pay $240MM for a second stent would be absolutely crazy. But stranger things have happened.

I thought COV owned approx. 25% of IDEV?

 

It's hard to believe but I hear Boston Scientific bought Idev

 

Me 2, heard just yesterday, in fact. Something must be up

 

So in the last week, we've heard ABT, COV, and Boston bought IDEV?

In other words, IDEV reps are trying to give the impression someone wants this POS?

IDEV selling out would be the best thing to happen to me. The invested docs get their payday, and they can start stenting with what is best for the patient again. Imagine that.

 

Boston is the winner and press release is expected by May 7. Someone actually purchased this vessel ripper.

 

which year - obviously not 2013!

 

Boston bought it but they are want their R&D team to be comfortable with the deployment system before the announcement. Look for an announcement in mid to late 2016.

 

So, mid to late 2016 before Boston R&D get comfortable? Guess the problem with trying to control placement must be much bigger than even Idev thought!!

 

How does that work? You buy something now but don't annouce it for 2-3 years

 

It's called sarcasm, dipshit.

 

A dipshit is the tool they used to inseminate that cow of a mother of yours.